Page 23 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 10 ฉบับที่ 3

Journal of Thai Traditional & Alternative Medicine Vol. 10 No. 3 September-December 2012 173

64 significance. Clin Microbiol Rev 1992;5:387-99.
carvacrol) À√◊Õ essential oils ®“° Thymus
7. Stapleton PD, Taylor PW. Methicillin resistance in
marocanus ·≈– Thymus broussonetii ´÷Ëß≈¥°“√
Staphylococcus aureus: mechanisms and modulation. Sci
¥◊ÈÕμàÕ¬“ chloramphenical ¢Õß S. Typhimurium Prog 2002;85:57-72.
8. Wright GD. Bacterial resistance to antibiotics: enzymatic
61
·≈– P. aeruginosa ‡ªìπμâπ
degradation and modification. Adv Drug Deliv Rev 2005;
57:1451-1470.
∫∑ àß∑⓬ 9. Hemaiswarya S, Doble M. Synergistic interaction of eugenol
with antibiotics against Gram negative bacteria.
°“√„™â “√≈¥°“√¥◊ÈÕ¬“∑”„À⬓ªØ‘™’«π–ÕÕ° Phytomedicine 2009;16:997-1005.
10. Wagner H. Synergy research: approaching a new
ƒ∑∏‘ω¥â°«â“ߢ÷Èπ “¡“√∂„™â„π°“√√—°…“‚√§‰¥âπ“π¢÷Èπ
generation of phytopharmaceuticals. Fitoterapia 2010;
·≈–≈¥ªí≠À“„π°“√‡°‘¥·∫§∑’‡√’¬¥◊ÈÕ¬“ ¥—ßπ—Èπ 82:34-7.
11. Wagner H, Ulrich-Merzenich G. Synergy research:
∏√√¡™“μ‘‚¥¬‡©æ“–æ◊™ ¡ÿπ‰æ√´÷Ëß¡’°“√»÷°…“‡°’ˬ«
approaching a new generation of phytopharmaceuticals.
°—∫ “√Õߧåª√–°Õ∫ ”§—≠¡“‡ªìπ‡«≈“π“π ®÷߇ªìπ Phytomedicine 2009;16:97-110.
12. McCormack PL, Keating GM. Amoxicillin/clavulanic acid
·À≈àß∑’Ëπà“ π„®¢Õß°“√»÷°…“ “√≈¥°“√¥◊ÈÕ¬“‡æ◊ËÕ
2000mg/125mg extended release (XR): a review of its
π”¡“„™â√à«¡°—∫¬“ªØ‘™’«π– ‡æ◊ËÕ‡æ‘Ë¡ª√– ‘∑∏‘º≈„Àâ use in the treatment of respiratory tract infections in adults.
°—∫¬“ ≈¥°“√¥◊ÈÕ¬“¢Õ߇™◊ÈÕ·∫§∑’‡√’¬ ∑”„À⇙◊ÈÕ∑’Ë Drugs 2005;65:121-36.
13. Sanchez Navarro A. New formulations of amoxicillin/
¥◊ÈÕ¬“·≈â«°≈—∫¡“‰«μàÕ¬“·≈–≈¥°“√Õÿ∫—μ‘„À¡à¢Õß
clavulanic acid: a pharmacokinetic and pharmacodynamic
“¬æ—π∏ÿå¥◊ÈÕ¬“‰¥âμàÕ‰ª review. Clin Pharmacokinet 2005;44:1097-115.
14. Sheldon AT Jr. Antibiotic resistance: a survival strategy.
Clin Lab Sci 2005;18:170-80.
15. Estes K. Methicillin-resistant Staphylococcus aureus skin
‡Õ° “√Õâ“ßÕ‘ß
and soft tissue infections. Impacting patient care. Crit
1. Johnson AP. Methicillin-resistant Staphylococcus aureus: Care Nurs Q 2011;34:101-9.
the European landscape. J Antimicrob Chemother 2011; 16. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K.
66:iv43-iv48. Synergy in a medicinal plant: antimicrobial action of
2. Bradford PA. Extended-spectrum beta-lactamases in the berberine potentiated by 5'-methoxyhydnocarpin, a
21st century: characterization, epidemiology, and detection multidrug pump inhibitor. Proc Natl Acad Sci U S A 2000;
of this important resistance threat. Clin Microbiol Rev 97:1433-7.
2001;14:933-951. 17. Stermitz FR, Tawara-Matsuda J, Lorenz P, Mueller P,
3. Anunnatsiri S, Tonsawan P. Risk factors and clinical Zenewicz L, Lewis K. 5'-Methoxyhydnocarpin-D and
outcomes of multidrug-resistant Acinetobacter baumannii pheophorbide A: Berberis species components that
bacteremia at a university hospital in Thailand. Southeast potentiate berberine growth inhibition of resistant
Asian J Trop Med Public Health 2011;42:693-703. Staphylococcus aureus. J Nat Prod 2000;63:1146-9.
4. Evans BA, Hamouda A, Abbasi SA, Khan FA, Amyes SG. 18. Lewis K, Ausubel FM. Prospects for plant-derived
High prevalence of unrelated multidrug-resistant antibacterials. Nat Biotechnol 2006;24:1504-7.
Acinetobacter baumannii isolates in Pakistani military 19. Ball AR, Casadei G, Samosorn S, Bremner JB, Ausubel
hospitals. Int J Antimicrob Agents 2011;37:580-581. FM, Moy TI, et al. Conjugating berberine to a multidrug
5. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins efflux pump inhibitor creates an effective antimicrobial.
and carbapenems in Gram-negative bacterial pathogens. ACS Chem Biol 2006;1:594-600.
Int J Med Microbiol 2010;300:371-9. 20. Bonapace CR, Bosso JA, Friedrich LV, White RL.
6. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance Comparison of methods of interpretation of checkerboard
to tetracycline: mechanisms, transfer, and clinical synergy testing. Diagn Microbiol Infect Dis 2002;44:363-